Mesoblast (MESO) Reports Q2 Loss of $0.05/Share
Tweet
Share
E-mailGet Alerts MESO Hot Sheet
Join SI Premium – FREE
Mesoblast (NASDAQ: MESO) reported Q2 EPS of ($0.05), versus ($0.29) reported last year. Revenue for the quarter came in at $1.87 million, versus $13.4 million reported last year.
For earnings history and earnings-related data on Mesoblast (MESO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
- Femasys Inc. (FEMY) Misses Q2 EPS by 20c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
